FOXO3 and Alzheimer disease: The entry of nonphosphorylated FOXO3a into the nucleus may also promote the transcription of lysosome‐related genes compensatorily, which may explain the rapid increase in the expression of lysosome‐related genes in late AD; however, this possibility requires further verification.